Recombinant CD4 (Ibalizumab Biosimilar) anticorps

N° du produit ABIN7795119

L’anticorps anti-CD4 (Ibalizumab Biosimilar) Monoclonal Souris est utilisé pour la détection de CD4 (Ibalizumab Biosimilar) dans des échantillons de Humain. Il a été validé pour FACS et in vivo.

Aperçu rapide pour Recombinant CD4 (Ibalizumab Biosimilar) anticorps (ABIN7795119)

Antigène: CD4 (Ibalizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CD4 (Ibalizumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Classe de qualité: Research Grade

Détail du produit anti-CD4 (Ibalizumab Biosimilar) anticorps

Expression System: Mammalian cells

Fonction: Ibalizumab Biosimilar, Human CD4 Monoclonal Antibody

Attributs du produit: What is ibalizumab biosimilar research grade? Ibalizumab Biosimilar uses the same protein sequences as the therapeutic antibody ibalizumab which is a non-immunosuppressive humanised monoclonal antibody that binds CD4, the primary receptor for HIV, and inhibits HIV from entering cells. It is a post-attachment inhibitor, blocking HIV from binding to the CCR5 and CXCR4 co-receptors after HIV binds to the CD4 receptor on the surface of a CD4 cell. Post-attachment inhibitors are a subclass of HIV drugs called entry inhibitors.

Purification: Protein A or G affinity column

Pureté: >95 % by reducing SDS-PAGE

niveau d'endotoxine: < 1 EU per 1 mg of the protein by the LAL method

Immunogène: Human CD4

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: > 3 mg/mL

Stock: 4 °C,-20 °C

Stockage commentaire: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Détails sur CD4 (Ibalizumab Biosimilar)

Antigène: CD4 (Ibalizumab Biosimilar)

Autre désignation: Ibalizumab Biosimilar

Classe de substances: Biosimilar